On Thursday, January 27, pharmaceutical giant Moderna announced that it had officially started Phase 1 of its HIV vaccine trial.
The company developed the shot in partnership with the International AIDS Vaccine Initiative (IAVI), with the first doses being administered at George Washington University School of Medicine and Health Sciences in Washington, DC.